Welcome to our dedicated page for Azelis Group N V news (Ticker: AZLGY), a resource for investors and traders seeking the latest updates and insights on Azelis Group N V stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Azelis Group N V's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Azelis Group N V's position in the market.
Azelis Group NV has announced the completion of its Share Buyback Program 2023, under which it repurchased 150,000 shares for a total amount of EUR 3,408,076.30, representing 0.064% of outstanding shares. The program was initiated on
Azelis Group NV announced a transparency notification on April 11, 2023, indicating that the Public Sector Pension Investment Board (PSP Investments) sold shares, reducing its stake below 10% on April 6, 2023. Following the transaction, PSP Investments holds 20,787,122 shares, representing 8.89% of the total shares outstanding (233,846,153), down from the previous holding of 12.14% (28,387,122 shares) reported in October 2021. The reduction signifies a shift in control dynamics as PSP Investments was previously one of the significant shareholders. The overall notification is mandated under the Belgian Transparency law of May 2, 2007.
Azelis, a global provider in specialty chemicals and food ingredients, has announced an agreement to acquire majority shares of Vogler Ingredients Ltda, a specialty distributor in Brazil. This acquisition aims to enhance Azelis' presence in Latin America, particularly in Brazil, which is the largest economy in the region. Vogler, with its established market expertise and extensive customer base of 2,300, will provide significant synergies for Azelis. The deal is expected to close in Q2 2023, pending customary conditions. This merger aligns with Azelis' strategy to grow in the food and nutrition sectors and leverage its international infrastructure.
Azelis Group NV has initiated a Share Buyback Program 2023, aiming to repurchase up to 150,000 ordinary shares for a maximum total of EUR 3,500,000. The program began on
Azelis Group NV has initiated a Share Buyback Program, planning to repurchase up to 150,000 shares, totaling a maximum of EUR 3,500,000. The program aims to cover future obligations under the Long-Term Incentive Plan. As of March 30, 2023, Azelis has repurchased 57,500 shares for EUR 1,349,566, representing 0.025% of total shares outstanding. Recent purchases include 12,000 shares at an average price of 23.08 €. This strategy is expected to enhance shareholder value by potentially increasing earnings per share and demonstrating the company's confidence in future growth.
Azelis Group NV has initiated a Share Buyback Program 2023, purchasing up to 150,000 ordinary shares for a total maximum amount of EUR 3,500,000. As of March 23, 2023, the company has repurchased 30,000 shares at an average price of 23.50 € to cover obligations under its Long-Term Incentive Plan. This buyback represents approximately 0.013% of the total shares outstanding, indicating strong shareholder value enhancement. The total expenditure so far amounts to EUR 713,548.80.
Azelis has announced the initiation of its Share Buyback Program 2023, effective from
Azelis Group reported a substantial revenue growth of 45.3% year-on-year, reaching EUR 4.1 billion for 2022. Organic growth was 20.1%, with strong contributions from Life Sciences (40.7%) and Industrial Chemicals (53.0%). Adjusted EBITA surged 70.5% to EUR 456.9 million, with a margin of 11.1%. Free Cash Flow rose 141.2% to EUR 438 million, showcasing a conversion rate of 94.8%. The company completed 12 acquisitions, boosting annualized revenue by over EUR 620 million. A dividend of EUR 67.8 million, or EUR 0.29 per share, was proposed. The management expects 8%-10% revenue growth in the medium term.
Azelis Group NV disclosed a transparency notification on January 31, 2023, indicating that EQT VIII Fund reduced its shareholding below 50%, specifically to 49.99%. This decrease followed a disposal of voting securities on January 26, 2023. Prior to this, EQT VIII Fund held 50.97% of the shares. The total number of shares is 233,846,153, meaning EQT VIII Fund now possesses 116,899,284 shares with voting rights. This shift indicates a significant decrease in control over the company by EQT VIII Fund. Detailed notifications regarding the holding and voting rights adjustments were shared as part of the regulatory requirements.
Azelis has announced the acquisition of 100% of Lidorr Elements, a leading specialty chemical distributor in Israel, enhancing its presence in the region. This strategic move expands Azelis’ lateral value chain in Agricultural & Environmental Solutions and Advanced Materials & Additives. Lidorr’s extensive product portfolio strengthens Azelis’ offerings to over 400 customers, including major Israeli manufacturers and retailers. Founded in 1970, Lidorr has a strong operational base, including 90 employees and a logistics facility in Beit Shemesh. The acquisition is expected to create synergies, improve customer service, and provide new business opportunities in crop protection and personal care.